GlassScriptPhysician profile
Mary Conners
NPI 1013906163
$1,151.96
in general payments reported to CMS, 2019-2025
17 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.00 · 2022: $53.00 · 2023: $262 · 2024: $524 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,063 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.34 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $252.67 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $249.11 | 2023-2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $218.08 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $82.48 | 2023-2024 | Airsupra, Farxiga |
| Pfizer INC. | $46.82 | 2024-2025 | |
| Amgen INC. | $45.36 | 2024 | Repatha, Otezla |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $44.63 | 2025 | Caplyta |
| Exact Sciences Corporation | $31.92 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dexcom, INC. | $31.40 | 2024-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.24 | 2024-2025 | Jardiance |
| Glaxosmithkline, LLC. | $26.27 | 2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Organon LLC | $21.30 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $16.00 | 2021 | |
| Phathom Pharmaceuticals, INC. | $15.09 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $13.90 | 2025 | Trintellix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13.04 | 2023 | Xarelto |
| Abbvie INC. | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Conners listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.